ASAH1 Antibody (2C9)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This gene encodes a heterodimeric protein consisting of a nonglycosylated alpha subunit and a glycosylated beta subunit that is cleaved to the mature enzyme posttranslationally. The encoded protein catalyzes the synthesis and degradation of ceramide into sphingosine and fatty acid. Mutations in this gene have been associated with a lysosomal storage disorder known as Farber disease. Multiple transcript variants encoding several distinct isoforms have been identified for this gene.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 2 of 2.

Publications using H00000427-M01	Applications	Species
Singh AT, Dharmarajan A, Aye IL, Keelan JA. Ceramide biosynthesis and metabolism in trophoblast syncytialization. Mol Cell Endocrinol. 2012-05-18 [PMID: 22652149]
Ruckhaberle E, Holtrich U, Engels K et al. Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer. Climacteric 2009-12-01 [PMID: 19905902]

Array H00000427-M01

• ASAH1 Antibodies
• ASAH1 ELISA Kits
• ASAH1 Lysate
• ASAH1 Proteins